In a move that could expand insurance coverage, the FDA approved Wegovy for heart health benefits

Novovo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage. That decision could widen insurance coverage for the drug and similar treatments for obesity, which has been a major barrier to access for patients. The drug could widen coverage for obesity treatments.

Novo Nordisk to increase supply of popular weight-loss drug Wegovy. The company says it has started to increase the availability of the drug for people in the U.S. Novi Nordisk says it is increasing the supply of the popular drug in the United States.

Novo Nordisk is gradually increasing supply of its highly sought-after weight loss drug Wegovy. The Danish drug manufacturer had to limit supply after frenzied demand forced it to limit supplies. Novo is increasing supply as demand continues to grow. Novi Nordisk says demand for the weight-loss drug continues to rise.